(Reuters) – Britain’s antitrust regulator said on Wednesday it has launched an investigation into Swiss drugmaker Vifor Pharma for suspected anti-competitive conduct in the supply of its blockbuster iron deficiency medicine Ferinject.
(Reporting by Eva Mathews in Bengaluru; Editing by Pooja Desai)
Comments